Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

[Rituximab for managing refractory thrombotic thrombocytopenic purpura: a report of three cases].

Yamanouchi J, Hato T, Miyoshi K, Kobayashi S, Azuma T, Hasegawa H, Yasukawa M.

Rinsho Ketsueki. 2013 Feb;54(2):205-9. Japanese.

PMID:
23470828
2.

Rituximab for thrombotic thrombocytopenic purpura: benefit of early administration during acute episodes and use of prophylaxis to prevent relapse.

Westwood JP, Webster H, McGuckin S, McDonald V, Machin SJ, Scully M.

J Thromb Haemost. 2013 Mar;11(3):481-90. doi: 10.1111/jth.12114.

3.

Combination of rituximab with therapeutic plasma exchange in a refractory case of thrombotic thrombocytopenic purpura (TTP).

Hans R, Sharma RR, Marwaha N.

Transfus Apher Sci. 2013 Oct;49(2):231-3. doi: 10.1016/j.transci.2012.09.007. Epub 2013 Mar 5.

PMID:
23466013
4.

A phase-II sequential case-series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab.

Clark WF, Rock G, Barth D, Arnold DM, Webert KE, Yenson PR, Kelton JG, Li L, Foley SR; members of Canadian Apheresis Group.

Br J Haematol. 2015 Jul;170(2):208-17. doi: 10.1111/bjh.13408. Epub 2015 Apr 8.

PMID:
25855259
5.

Short- and long-term effects of rituximab for the treatment of thrombotic thrombocytopenic purpura: four case reports.

Iioka F, Shimomura D, Ishii T, Maesako Y, Ohgoe K, Nakamura F, Matsuo S, Ohno H.

Int J Hematol. 2012 Oct;96(4):506-12. doi: 10.1007/s12185-012-1162-2. Epub 2012 Aug 10.

PMID:
22878941
6.

Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: results of a Spanish multicenter study.

de la Rubia J, Moscardó F, Gómez MJ, Guardia R, Rodríguez P, Sebrango A, Zamora C, Debén G, Goterris R, López R, Peña F, Pujol M, Vidaller A, Del Río-Garma J, Sanz MA; Grupo Español de Aféresis.

Transfus Apher Sci. 2010 Dec;43(3):299-303. doi: 10.1016/j.transci.2010.09.018. Epub 2010 Oct 12.

PMID:
20934383
7.

Successful treatment with rituximab in a patient with TTP secondary to severe ANCA-associated vasculitis.

Asamiya Y, Moriyama T, Takano M, Iwasaki C, Kimura K, Ando Y, Aoki A, Kikuchi K, Takei T, Uchida K, Nitta K.

Intern Med. 2010;49(15):1587-91. Epub 2010 Aug 2.

8.

Sustained response with rituximab in patients with thrombotic thrombocytopenic purpura: a report of 13 cases and review of the literature.

Ling HT, Field JJ, Blinder MA.

Am J Hematol. 2009 Jul;84(7):418-21. doi: 10.1002/ajh.21439. Review.

9.

[Efficacy and safety of rituximab therapy for refractory/relapsing thrombotic thrombocytopenic purpura].

Cui J, Zhu TN, Zou N, Chen M, Zhao YQ.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2013 Feb;35(1):116-20. doi: 10.3881/j.issn.1000-503X.2013.01.022. Chinese.

10.

Chronic relapsing thrombotic thrombocytopenic purpura successfully treated with rituximab: case report.

Gianfaldoni G, Antonioli E, Mannelli F, Vannucchi AM, Bosi A.

J Chemother. 2005 Aug;17(4):449-51.

PMID:
16167526
11.

Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura.

Bhagirath VC, Kelton JG, Moore J, Arnold DM.

Transfusion. 2012 Dec;52(12):2517-23. doi: 10.1111/j.1537-2995.2012.03635.x. Epub 2012 Apr 4.

PMID:
22486316
12.

Rituximab for acute plasma-refractory thrombotic thrombocytopenic purpura. A case report and concise review of the literature.

Rüfer A, Brodmann D, Gregor M, Kremer Hovinga JA, Lämmle B, Wuillemin WA.

Swiss Med Wkly. 2007 Sep 22;137(37-38):518-24. Review.

13.

Rapid and complete resolution of chemotherapy-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) with rituximab.

Gourley BL, Mesa H, Gupta P.

Cancer Chemother Pharmacol. 2010 Apr;65(5):1001-4. doi: 10.1007/s00280-010-1258-4. Epub 2010 Jan 30.

PMID:
20119714
14.

Refractory thrombotic thrombocytopenic purpura associated with primary Sjogren syndrome treated with rituximab: a case report.

Toumeh A, Josh N, Narwal R, Assaly R.

Am J Ther. 2014 Mar-Apr;21(2):e56-60. doi: 10.1097/MJT.0b013e3182459aa0.

PMID:
23011161
15.

Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.

Koulova L, Alexandrescu D, Dutcher JP, O'Boyle KP, Eapen S, Wiernik PH.

Am J Hematol. 2005 Jan;78(1):49-54.

16.

Successful treatment with rituximab for acute refractory thrombotic thrombocytopenic purpura related to acquired ADAMTS13 deficiency: a pediatric report and literature review.

Harambat J, Lamireau D, Delmas Y, Ryman A, Llanas B, Brissaud O.

Pediatr Crit Care Med. 2011 Mar;12(2):e90-3. doi: 10.1097/PCC.0b013e3181e89f8f.

PMID:
20625343
17.

Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center.

Froissart A, Buffet M, Veyradier A, Poullin P, Provôt F, Malot S, Schwarzinger M, Galicier L, Vanhille P, Vernant JP, Bordessoule D, Guidet B, Azoulay E, Mariotte E, Rondeau E, Mira JP, Wynckel A, Clabault K, Choukroun G, Presne C, Pourrat J, Hamidou M, Coppo P; French Thrombotic Microangiopathies Reference Center.

Crit Care Med. 2012 Jan;40(1):104-11. doi: 10.1097/CCM.0b013e31822e9d66.

PMID:
21926591
18.

Current management and therapeutical perspectives in thrombotic thrombocytopenic purpura.

Coppo P, Veyradier A.

Presse Med. 2012 Mar;41(3 Pt 2):e163-76. doi: 10.1016/j.lpm.2011.10.024. Epub 2012 Jan 21. Review.

PMID:
22265954
19.

A dramatic response to rituximab in a patient with resistant thrombotic thrombocytopenic purpura (TTP) who developed acute stroke.

Ozdogu H, Boga C, Kizilkilic E, Yeral M, Kozanoglu I, Karatas M.

J Thromb Thrombolysis. 2007 Apr;23(2):147-50. Epub 2007 Jan 13.

PMID:
17221322
20.

Rituximab for refractory and or relapsing thrombotic thrombocytopenic purpura related to immune-mediated severe ADAMTS13-deficiency: a report of four cases and a systematic review of the literature.

Elliott MA, Heit JA, Pruthi RK, Gastineau DA, Winters JL, Hook CC.

Eur J Haematol. 2009 Oct;83(4):365-72. doi: 10.1111/j.1600-0609.2009.01292.x. Epub 2009 Jun 8. Review.

PMID:
19508684
Items per page

Supplemental Content

Write to the Help Desk